BIOMAT Database Logo BIOMAT Database Logo

[Sotalol (Sotacor). A different beta blockader with class II and III anti-arrhythmia]. 1991

F E Nielsen, and H T Sørensen
Medicinsk afdeling F, Københavns Amts Sygehus i Herlev.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D013015 Sotalol An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias. Darob,MJ-1999,Sotalol Hydrochloride,Sotalol Monohydrochloride,MJ 1999,MJ1999

Related Publications

F E Nielsen, and H T Sørensen
Sotalol: a novel beta-blocker with class III anti-arrhythmic activity.
June 1993, Journal of clinical pharmacology,
F E Nielsen, and H T Sørensen
[Pharmacoketics of the beta-adrenergic blockader sotalol].
January 1974, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
F E Nielsen, and H T Sørensen
[Sotalol. Beta-blockade and class III antiarrhythmic effect].
November 1990, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
F E Nielsen, and H T Sørensen
d-Sotalol: a new potent class III anti-arrhythmic agent.
November 1985, Clinical science (London, England : 1979),
F E Nielsen, and H T Sørensen
[Stepwise plan for anti-arrhythmia therapy. Sotalol: the class III anti-arrhythmia agent in the foreground. Report from the news conference: Anti-Arrhythmia Therapy. Frankfurt, 13 October 1993].
January 1994, Fortschritte der Medizin. Supplement : die Kongressinformation fur die Praxis,
F E Nielsen, and H T Sørensen
[Hemodynamic effects of class-I and class-III anti-arrhythmia agents].
June 1989, Deutsche medizinische Wochenschrift (1946),
F E Nielsen, and H T Sørensen
Clinical electrophysiology of intravenous sotalol, a beta-blocking drug with class III antiarrhythmic properties.
May 1984, American heart journal,
F E Nielsen, and H T Sørensen
[Therapy of atrial fibrillation with class III anti-arrhythmia agents].
February 1993, Herz,
F E Nielsen, and H T Sørensen
Comparison of class II and class III activity of dl-sotalol in healthy volunteers.
January 1998, Japanese heart journal,
F E Nielsen, and H T Sørensen
Sotalol: a new class III antiarrhythmic agent.
December 1993, Clinical pharmacy,
Copied contents to your clipboard!